Tocilizumab in Giant Cell Arteritis: Better Understanding the Benefits.

Frank Buttgereit, Andriko Palmowski, Idil Esen, Elisabeth Brouwer

April 2023 Arthritis Rheumatol

Synopsis of Social media discussions

Many social discussions emphasize the importance of understanding Tocilizumab's benefits, using words like 'better understanding' and 'editorial,' indicating respect for the publication. The tone is primarily informative and reflective, with some posts sharing the original editorial to highlight its relevance, illustrating a shared interest in advancing knowledge about GCA treatment.

A
Agreement
 Moderate agreement

Most discussions acknowledge the article's focus on Tocilizumab's benefits for GCA, showing general consensus that its insights are valuable.

I
Interest
 High level of interest

The high interest score reflects active engagement with the topic, as multiple posts share enthusiasm and highlight the significance of new research.

E
Engagement
 Moderate level of engagement

Posts include references to the editorial and reposted content, indicating participants are engaging with the material beyond superficial mentions.

I
Impact
 Moderate level of impact

The moderate impact score suggests that while the discussions recognize the importance of the findings, widespread change in practice or perception is still developing.

Social Mentions

YouTube

2 Videos

Facebook

1 Posts

Twitter

14 Posts

News

5 Articles

Metrics

Video Views

24

Total Likes

35

Extended Reach

47,575

Social Features

22

Timeline: Posts about article

Top Social Media Posts

Posts referencing the article

Tocilizumab's Role in Improving Giant Cell Arteritis Treatment

Tocilizumab's Role in Improving Giant Cell Arteritis Treatment

Tocilizumab is used to treat Giant Cell Arteritis, an inflammatory large vessel disease. Recent research indicates it controls symptoms more effectively with fewer side effects compared to steroids, improving disease management and patient outcomes.

ReumaTimes

May 1, 2023

24 views

Tocilizumab Enhances Giant Cell Arteritis Treatment Effectiveness

Tocilizumab Enhances Giant Cell Arteritis Treatment Effectiveness

Tocilizumab is a medication used to treat Giant Cell Arteritis, an inflammatory condition affecting large blood vessels. Recent research shows it can better control symptoms with fewer side effects than steroids, potentially improving future treatment strategies.

ReumaTimes

October 17, 2024

0 views

  • Luis Alberto Ramírez Gómez
    @LuisAlb54295075 (Twitter)

    RT @ACR_Journals: New Editorial from Arthritis & Rheumatology: Tocilizumab in Giant Cell Arteritis: Better Understanding the Benefits htt…
    view full post

    February 27, 2023

    1

  • ACR_Journals
    @ACR_Journals (Twitter)

    New Editorial from Arthritis & Rheumatology: Tocilizumab in Giant Cell Arteritis: Better Understanding the Benefits https://t.co/ucOvPqZTwd
    view full post

    February 26, 2023

    7

    1

  • Specialist MD
    @rheumatics (Twitter)

    RT @ACR_Journals: New Editorial from Arthritis & Rheumatology: TOCILIZUMAB IN GIANT CELL ARTERITIS: BETTER UNDERSTANDING THE BENEFITS htt…
    view full post

    January 8, 2023

    5

  • Sr. Kame
    @Dark_R4ven (Twitter)

    RT @ACR_Journals: New Editorial from Arthritis & Rheumatology: TOCILIZUMAB IN GIANT CELL ARTERITIS: BETTER UNDERSTANDING THE BENEFITS htt…
    view full post

    January 5, 2023

    5

  • Ángel Robles Marhuenda
    @AngelRoblesMarh (Twitter)

    RT @ACR_Journals: New Editorial from Arthritis & Rheumatology: TOCILIZUMAB IN GIANT CELL ARTERITIS: BETTER UNDERSTANDING THE BENEFITS htt…
    view full post

    January 5, 2023

    5

  • Luis Caminal
    @caminalm (Twitter)

    RT @ACR_Journals: New Editorial from Arthritis & Rheumatology: TOCILIZUMAB IN GIANT CELL ARTERITIS: BETTER UNDERSTANDING THE BENEFITS htt…
    view full post

    January 4, 2023

    5

  • Nouf Al hemmadi
    @NoufAhmedAlham2 (Twitter)

    RT @ACR_Journals: New Editorial from Arthritis & Rheumatology: TOCILIZUMAB IN GIANT CELL ARTERITIS: BETTER UNDERSTANDING THE BENEFITS htt…
    view full post

    January 4, 2023

    5

  • ACR_Journals
    @ACR_Journals (Twitter)

    New Editorial from Arthritis & Rheumatology: TOCILIZUMAB IN GIANT CELL ARTERITIS: BETTER UNDERSTANDING THE BENEFITS https://t.co/ucOvPqZTwd
    view full post

    January 4, 2023

    13

    5

  • Luis Caminal
    @caminalm (Twitter)

    TOCILIZUMAB IN GIANT CELL ARTERITIS: BETTER UNDERSTANDING THE BENEFITS https://t.co/n7nStQRlxC
    view full post

    December 15, 2022

    1

  • Neslihan Gokcen
    @NeslihanGken7 (Twitter)

    RT @vasculitides: TOCILIZUMAB IN GIANT CELL ARTERITIS: BETTER UNDERSTANDING THE BENEFITS - Editorial - Arthritis Rheumatol https://t.co/BVQ…
    view full post

    December 14, 2022

    4

  • Numune Aliyeva
    @AliyevaNumune (Twitter)

    RT @vasculitides: TOCILIZUMAB IN GIANT CELL ARTERITIS: BETTER UNDERSTANDING THE BENEFITS - Editorial - Arthritis Rheumatol https://t.co/BVQ…
    view full post

    December 13, 2022

    4

  • Nouf Al hemmadi
    @NoufAhmedAlham2 (Twitter)

    RT @vasculitides: TOCILIZUMAB IN GIANT CELL ARTERITIS: BETTER UNDERSTANDING THE BENEFITS - Editorial - Arthritis Rheumatol https://t.co/BVQ…
    view full post

    December 13, 2022

    4

  • Juan Molina Collada
    @jmolinacollada (Twitter)

    https://t.co/ZZAkXfAFXo
    view full post

    December 13, 2022

    2

  • vasculitides
    @vasculitides (Twitter)

    TOCILIZUMAB IN GIANT CELL ARTERITIS: BETTER UNDERSTANDING THE BENEFITS - Editorial - Arthritis Rheumatol https://t.co/BVQXu99VVd
    view full post

    December 13, 2022

    10

    4

  • Progress of Alkaline Anion Exchange Membranes For Fuel Cells ...

    The state-of-the-art Nafion to design the chemical structure of polymer backbone, and ... doi: 10.1002/cssc.201701600 via ROMP of trans-cyclooctene derivatives.
    view full post

    December 15, 2025

    News

  • Thermo Named Reactions Organic Synthesis Ebook | PDF ...

    ChemCatChem 2016, 8: 1998 – 2009 https://doi.org/10.1002/cctc.201600134. ... 42414 7V[HZZP\T O`KYV_PKL JH (*: YLHNLU[ WLSSL[Z 23255 7V[HZZP\T O`KYV_PKL JH ...
    view full post

    December 15, 2025

    News

  • Named Reactions Organic Synthesis Ebook | PDF | Ester | Chemical ...

    ChemCatChem 2016, 8: 1998 – 2009 https://doi.org/10.1002/cctc.201600134. ... 42414 Potassium hydroxide, ca. 85%, ACS reagent, pellets 23255 Potassium ...
    view full post

    December 15, 2025

    News

  • Pulmonary Vasculature Redox Signaling in Health and Disease by ...

    produced using Servier Medical Art (www.servier.com). conditioning ... 10.1002/mnfr.201100279. Toxicology, 9, 35. doi:10.1186/1743-8977-9-35. 180 ...
    view full post

    December 15, 2025

    News

  • I came upon an opportunity to express my opinions of the Heart and ...

    Now Art was a heavy smoker and I wanted to see if there could have been a connection to wood burning and fire pits and it turns out it can ...
    view full post

    May 20, 2022

    Facebook

  • Sсiеncе - 19 December 2014 | PDF | Science | Physics

    ART ASSOCIATES Holly Bishop, Preston Huey ART ASSOCIATES Kay Engman, Garvin Grulln, ... 42414. 2. G. Burnstock, Med. Hypotheses 73, 470 ...
    view full post

    December 19, 2014

    News

Abstract Synopsis

  • Tocilizumab is a medication used to treat Giant Cell Arteritis (GCA), an inflammatory condition affecting large blood vessels.
  • The article discusses recent research showing that Tocilizumab can help control GCA symptoms more effectively and with fewer side effects compared to traditional treatments like steroids.
  • Overall, the study suggests that understanding how Tocilizumab benefits GCA patients could improve how doctors manage and treat the disease in the future.]